Your browser doesn't support javascript.
loading
Pediatric thyroid-like follicular renal cell carcinoma-a post-neuroblastoma case with comprehensive genomic profiling data.
Kiss, Richárd; Micsik, Tamás; Bedics, Gábor; Papp, Gergo; Csóka, Monika; Jenovári, Zoltán; Szabó, Sándor; Tornóczki, Tamás; Vujanic, Gordan; Kuthi, Levente.
Afiliação
  • Kiss R; Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Micsik T; Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Bedics G; Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Papp G; Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Csóka M; Tuzoltó Street Department, Pediatric Center, Semmelweis University, Budapest, Hungary.
  • Jenovári Z; Tuzoltó Street Department, Pediatric Center, Semmelweis University, Budapest, Hungary.
  • Szabó S; Tuzoltó Street Department, Pediatric Center, Semmelweis University, Budapest, Hungary.
  • Tornóczki T; Department of Pathology, Faculty of Medicine and Clinical Center, University of Pécs, Pécs, Hungary.
  • Vujanic G; Department of Pathology, Sidra Medicine, Doha, Qatar.
  • Kuthi L; Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary. kuthilevente@gmail.com.
Virchows Arch ; 2024 Jul 11.
Article em En | MEDLINE | ID: mdl-38990362
ABSTRACT
Thyroid-like follicular renal cell carcinoma (TLFRCC), an emerging subtype of renal cell carcinoma, presents diagnostic challenges due to its resemblance to normal thyroid tissue. Here, we report a rare case of TLFRCC in a pediatric patient, a demographic rarely affected by this subtype. Histologically resembling a typical TLFRCC, our case exhibited unique features including post-neuroblastoma development, occurrence in a male teenager, and diffuse MelanA expression, which has not been previously reported in TLFRCC. Comprehensive genomic profiling revealed the EWSR1PATZ1 fusion, confirming its genetic basis. Due to the advanced tumor stage, the patient received combined immunotherapy, and after a 9-month follow-up, remains tumor-free. Our case broadens the diagnostic spectrum of pediatric renal cell carcinomas, highlighting the importance of comprehensive molecular profiling in rare subtypes such as TLFRCC. Further research is needed to better understand TLFRCC's genetic landscape and optimize therapeutic strategies, especially in pediatric populations with evolving treatment protocols.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article